Abstract
For many years, tracers of perfusion have been used for the diagnosis of regional myocardial ischemia. For this purpose, thallium-201 has been, by far, the most widely used tracer in single photon scintigraphy. However, thallium-201 scintigraphy — even in the tomographic mode (SPECT) — underestimates regional viability, particularly after myocardial infarction. Tamaki et al. [1,2].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tamaki N, Ohtani H, Yonekura Y et al. Can reinjection of thallium-201 SPECT replace FDG-PET for assessing tissue viability [abstract]? J Nucl Med 1990; 31: 742.
Tamaki N, Ohtani H, Yamashita K et al. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose. J Nucl Med 1991; 32: 673–8.
Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose-fatty acid cycle. Lancet 1963; i: 785–9.
Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of the heart muscle. Annu Rev Physiol 1974; 36: 413–59.
Opie LH. Effect of regional ischemia on metabolism of glucose and fatty acids. Circ Res 1976; 38 Suppl 1:153–174.
Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Progr Cardiovasc Dis 1981; 23: 321–6.
Marshall RC, Tillisch JH, Phelps ME et al. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, F-18 labeled fluorodeoxyglucose and N13-ammonia. Circulation 1983; 67: 766–78.
De Landsheere C, Raets D, Pierard L et al. Residual metabolic abnormalities and regional viability after a myocardial infarction: a study using positron tomography, F-18 deoxyglucose and flow indicators [abstract]. J Am Coll Cardiol 1985a; 5: 451.
De Landsheere CM, Raets D, Pierard LA et al. Fibrinolysis and viable myocardium after an acute infarction: a study of regional perfusion and glucose utilization with positron emission tomography [abstract]. Circulation 1985b; 72(4 Suppl III): III393.
De Landsheere C, Raets D, Pierard L et al. Thrombolysis in anterior myocardial infarction: effect on regional viability studied with positron emission tomography [abstract]. Circulation 1987a; 76(4 Suppl IV): IV5.
De Landsheere C, Raets D, Pierard L et al. Investigation of myocardial viability after an acute myocardial infarction using positron emission tomography. In Heiss WD, Pawlik G, Herholz K, Wienhard K, editors. Clinical efficacy of positron emission tomography, Dordrecht: Martinus Nijhoff, 1987b: 279–96.
De Landsheere C, Raets D, Pierard L et al. Viabilité myocardique après infarctus du myocarde traité par fibrinolyse: évaluation directe par tomographie à émission de positons combinant une étude régionale de la perfusion et de la captation glucidique. J Biophys Bioméc 1987c; 11(Suppl 2): 185–7.
De Landsheere CM. Assessment of glucose utilization in normal and ischemic myocardium with positron emission tomography and 18F-deoxyglucose. In: Van der Wall E, editor. Noninvasive imaging of cardiac metabolism, Dordrecht: Martinus Nijhoff, 1987d: 241–63.
De Landsheere C, Raets D, Pierard L et al. Regional myocardial perfusion and glucose uptake: clinical experience in 92 cases studied with positron tomography [abstract]. Eur J Nucl Med 1989; 15: 446.
De Landsheere C. Contribution de la tomographie par émission de positons à l’étude de l’insuffisance coronarienne. Thèse d’agrégation de l’enseignement supérieur, 1990 [dissertation].
Rigo P, De Landsheere C, Raets D, Del Fiore G, Quaglia L, Lemaire C. Myocardial blood flow and glucose uptake after myocardial infarction. Eur J Nucl Med 1986; 12: S59–S61.
Pierard LA, De Landsheere C, Berthe C, Rigo P, Kulbertus HE. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cardiol 1990; 15: 1021–31.
Guttman I. Statistical tolerance regions. London: Griffin, 1970.
De Landsheere C, Pierard L, Melon P et al. Understanding perfusion and glucose uptake patterns by the use of low-dose dobutamine in 29 patients with anterior myocardial infarction. J Am Coll Cardiol 1992 [in press].
Grandin C, Melin JA, Essamri B et al. Prediction of functional improvement with PET in patients recovering from acute anterior ischemia [abstract]. J Nucl Med 1991; 32: 1012.
Schwaiger M, Hicks R. The clinical role of metabolic imaging of the heart by positron emission tomography. J Nucl Med 1991; 32: 565–78.
Schelbert HR. Assessment of myocardial viability with positron emission tomography. Proceedings of the third annual international PET conference of the Institute for Clinical PET. Washington D.C. 1991: 38–41.
Brunken R, Tillisch J, Schwaiger M et al. Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarctions: evidence for persistence of viable tissue in some infarct regions by positron emission tomography. Circulation 1986; 73: 951–63.
Tillisch J, Brunken R, Marshall l.et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986; 314: 884–8.
Tamaki N, Yonekura Y, Yamashita K et al. Positron emission tomography using fluorine-18-deoxyglucose in evaluation of coronary artery bypass grafting. Am J Cardiol 1989; 64: 860–5.
Al-Aouar ZR, Eitzman D, Hepner A et al. PET assessment of myocardial tissue viability. University of Michigan experience [abstract]. J Nucl Med 1990; 31: 801.
Brunken R, Schwaiger M, Grover-McKay M, Phelps ME, Tillisch J, Schelbert HR. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. J Am Coll Cardiol 1987; 10: 557–67.
Brunken RC, Kottou S, Nienaber CA et al. PET detection of viable tissue in myocardial segments with persistent defects at Tl-201 SPECT Radiology 1989; 172: 65–73.
Tamaki N, Yonekura Y, Yamashita K et al. Relation of left ventricular perfusion and wall motion with metabolic activity in persistent defects on thallium-201 tomography in healed myocardial infarction. Am J Cardiol 1988; 62: 202–8.
Bonow R, Dilsizian V, Cuocolo A, Bacharach S. Identification of viable myocardium in patients with chronic artery disease and left ventricular dysfunction: comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. Circulation 1991; 83: 26–37.
Eitzman D, Al-Azouar Z, Kanter L et al. Clinical outcome in patients with advanced coronary artery disease following PET viability studies [abstract]. J Nucl Med 1991; 32: 1011–2.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
de Landsheere, C., Piérard, L., Melon, P., Comar, D., Kulbertus, H.E., Rigo, P. (1992). Is it worth assessing regional myocardial viability with positron emission tomography?. In: van der Wall, E.E., Sochor, H., Righetti, A., Niemeyer, M.G. (eds) What’s New in Cardiac Imaging?. Developments in Cardiovascular Medicine, vol 133. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-2456-0_37
Download citation
DOI: https://doi.org/10.1007/978-94-011-2456-0_37
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5083-8
Online ISBN: 978-94-011-2456-0
eBook Packages: Springer Book Archive